Find therapies in clinical trials near you – page 51

Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Study Comparing ACP-196 and Ibrutinib for Patients with High-Risk Chronic Lymphocytic Leukemia

Study Comparing ACP-196 and Ibrutinib for Patients with High-Risk Chronic Lymphocytic Leukemia

Study on Anifrolumab for Adults with Active Lupus Nephritis

Study on Anifrolumab for Adults with Active Lupus Nephritis

Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease